 |
| From Innovation to Market |
 |
|
|
|
|
|
|
| |
Licensing
We are striving to find the appropriate licensing partner to commercialize our technologies in a
synergetic partnership. Our patented technologies have complemented the product portfolio of global
market leaders and have supported start-up companies in gaining their market position.
Private Equity
We also develop financial scenarios to offer our technologies for private equity investments.
Targeted investors are financial institutions, venture capital companies or individuals, sometimes
with a personal interest in business participation. Typically we choose to incorporate our technology
into a new company where we further develop and add value to it.
|
|
Doris Schäfer, CFO
We are committed to long term partnerships. And we are proud to celebrate the 25th anniversary of our co-operation with Alcon Laboratories, the global market leader in Ophthalmology. |
|
| |
© 2003-2007 Chemisches Institut Schäfer AG. All rights reserved.
|
